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ORAL PRESENTATION Open Access
The risks and benefits of RTPA in acute ischemic
stroke for patients at high risk of intracranial
haemorrhage and poor functional outcome:
a secondary analysis of the IST-3 trial and
systematic review of prediction models
Douglas Thompson1*, Gordon Murray1, William Whiteley1,2
From 2nd Clinical Trials Methodology Conference: Methodology Matters
Edinburgh, UK. 18-19 November 2013
Background
Treating acute ischaemic stroke patients with iv-rtPA is
of overall benefit. An associated increase in the risk of
symptomatic intracranial haemorrhage (SICH) may
cause considerable harm. We investigated (i) whether
novel or existing prediction models could predict SICH
or poor functional outcome in rtPA treated patients and
(ii) whether ischemic stroke patients at either a high
predicted risk of SICH or poor functional outcome
experienced less benefit from rtPA.
Methods
We used the IST-3 trial data, an international, multicen-
tre, open treatment randomised trial of rtPA versus con-
trol in 3035 acute ischemic stroke patients. We
developed and internally evaluated a multivariate logistic
regression model for SICH following rtPA including
variables identified as important in a systematic review.
We compared the discrimination (area under the recei-
ver operating characteristic curve (AUROCC)) of our
model with those existing in the medical literature. We
calculated the absolute risk reduction of death or depen-
dency with rtPA in patients at a low, medium or high
predicted risk of SICH or poor functional outcome with
each model.
Results
Our model had similar discrimination for SICH
(AUROCC 0.68 95% CI: 0.63-0.74) to nine previously
developed models (HAT, SEDAN, SITS, GRASPS,
SPAN-100, Stroke-TPI, DRAGON, THRIVE and a
model with NIHSS and age). There was no evidence
that patients at high predicted risk of SICH or poor
functional outcome after stroke derived less benefit
from rtPA.
Conclusions
We found no evidence to support a stratified approach
in administering rtPA to acute ischaemic stroke patients
at a high predicted risk of intracranial haemorrhage or
poor functional outcome.
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